Glycyrrhetinic acid

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Antiviral

Drug status

Used to treat other disease

2
Supporting references
0
Contradictory references
12
AI-suggested references
0
Clinical trials

 


Supporting references

AI-suggested references

Link Publication date
Phytonutrient Inhibitors of SARS-CoV-2/NSP5-Encoded Main Protease (Mpro) Autocleavage Enzyme Critical for COVID-19 Pathogenesis.
Apr/01/2022
Inhibition effects of eight anti-coronavirus drugs on glycosides metabolism and glycosidases in human gut microflora.
Sep/20/2021
Traditional Uses, Pharmacological Effects, and Molecular Mechanisms of Licorice in Potential Therapy of COVID-19
Jan/01/2021
Research Progress on the Antiviral Activity of Glycyrrhizin and its Derivatives in Liquorice
Jul/06/2021
Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome?
Mar/02/2021
Virtual screening of plant-derived compounds against SARS-CoV-2 viral proteins using computational tools.
Mar/17/2021
Anti-SARS-CoV-2 activities of tanshinone IIA, carnosic acid, rosmarinic acid, salvianolic acid, baicalein, and glycyrrhetinic acid between computational and in vitro insights
Sep/01/2021
Natural triterpenoids from licorice potently inhibit SARS-CoV-2 infection.
Nov/26/2021
Symptomatic Protective Action of Glycyrrhizin (Licorice) in COVID-19 Infection?
May/28/2020
Oncopreventive and oncotherapeutic potential of licorice triterpenoid compound glycyrrhizin and its derivatives: Molecular insights
Dec/11/2020
Glycyrrhetinic acid and its derivatives as potential alternative medicine to relieve symptoms in nonhospitalized COVID-19 patients
Jun/17/2020
Exploring the Pivotal Immunomodulatory and Anti-Inflammatory Potentials of Glycyrrhizic and Glycyrrhetinic Acids
Nov/06/2020